Vascular tissue engineering of small-diameter blood vessels: Reviewing the electrospinning approach

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 8, 2015, Pages 861-888

  Ercolani, Enrico ^a   Del Gaudio, Costantino ^a   Bianco, Alessandra ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biomaterials; Electrospinning; Small diameter graft; Vascular tissue engineering

Indexed keywords

BIOMATERIALS; BLOOD VESSELS; FUNCTIONAL POLYMERS; SCAFFOLDS (BIOLOGY); TISSUE;

BIOMEDICAL RESEARCH; BIORESORBABLE POLYMERS; BLOOD VESSEL SUBSTITUTES; EXTRACELLULAR MATRICES; FUNCTIONAL CHARACTERISTICS; FUNCTIONALIZED; INNOVATIVE SOLUTIONS; RESEARCH FIELDS; SMALL-DIAMETER GRAFT; VASCULAR TISSUE ENGINEERING;

ELECTROSPINNING;

BIOMATERIAL; COLLAGEN; ELASTIN; GELATIN; POLY(GLYCOLIC)ACID; POLYMER; SILK FIBROIN; UNCLASSIFIED DRUG; BIOSYN TERPOLYMER; DIOXANE DERIVATIVE; LACTIC ACID; LACTIDE-CAPROLACTONE COPOLYMER; POLYCAPROLACTONE; POLYDIOXANONE; POLYESTER; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYURETHAN;

BIORESORBABLE SCAFFOLD; BLOOD VESSEL DIAMETER; BLOOD VESSEL GRAFT; ELECTROSPINNING; EXTRACELLULAR MATRIX; FIBER; MICROENVIRONMENT; POLYMERIC FIBRE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; VASCULAR TISSUE; BLOOD VESSEL; BLOOD VESSEL PROSTHESIS; CHEMISTRY; HUMAN; METABOLISM; PATHOLOGY; PROCEDURES; TISSUE SCAFFOLD;

BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; COLLAGEN; DIOXANES; ELASTIN; EXTRACELLULAR MATRIX; HUMANS; LACTIC ACID; POLYDIOXANONE; POLYESTERS; POLYGLYCOLIC ACID; POLYMERS; POLYURETHANES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84938738126     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1697     Document Type: Review

References (129)

1. Allender S, Scarborough P, Peto V et al. 2008; European cardiovascular disease statistics. British Heart Foundation.
2. Altman GH, Diaz F, Jakuba C et al. 2003; Silk-based biomaterials. Biomaterials 24: 401-416.
3. Andukuri A, Kushwaha M, Tambralli A et al. 2011; A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants. Acta Biomater 7: 225-233.
4. Avci-Adali M, Ziemer G, Wendel HP. 2010; Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization - a review of current strategies. Biotechnol Adv 28: 119-129.
5. Badylak SF. 2002; The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 13: 377-383.
6. Baji A, Mai YW, Wong SC et al. 2010; Electrospinning of polymer nanofibers: effects on oriented morphology, structures and tensile properties. Compos Sci Technol 70: 703-718.
7. Bergmeister H, Grasl C, Walter I et al. 2012; Electrospun small-diameter polyurethane vascular grafts: ingrowth and differentiation of vascular-specific host cells. Artif Organs 36: 54-61.
8. Boland ED, Coleman BD, Barnes CP et al. 2005; Electrospinning polydioxanone for biomedical applications. Acta Biomater 1: 115-123.
9. Boland ED, Matthews JA, Pawlowski KJ et al. 2004; Electrospinning collagen and elastin: preliminary vascular tissue engineering. Front Biosci 9: 1422-1432.
10. Bonani W, Maniglio D, Motta A et al. 2011; Biohybrid nanofiber constructs with anisotropic biomechanical properties. J Biomed Mater Res B Appl Biomater 96: 276-286.
11. Buttafoco L, Kolkman NG, Engbers-Buijtenhuijs P et al. 2006a; Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27: 724-734.
12. Buttafoco L, Engbers-Buijtenhuijs P, Poot AA et al. 2006b; First steps towards tissue engineering of small-diameter blood vessels: preparation of flat scaffolds of collagen and elastin by means of freeze drying. J Biomed Mater Res B Appl Biomater 77: 357-368.
13. Cheng S, Craig WS, Mullen D et al. 1994; Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin αIIb β3 antagonists. J Med Chem 37: 1-8.
14. Coneski PN, Nash JA, Schoenfisch MH. 2011; Nitric oxide-releasing electrospun polymer microfibers. ACS Appl Mater Interfaces 3: 426-432.
15. Dahlke H, Dociu N, Thurau K. 1980; Thrombogenicity of different suture materials as revealed by scanning electron microscopy. J Biomed Mater Res 14: 251-268.
16. De Mel A, Jell G, Stevens MM et al. 2008; Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 9: 2969-2979.
17. De Visscher G, Mesure L, Meuris B et al. 2012; Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α. Acta Biomater 8: 1330-1338.
18. Del Gaudio C, Bianco A, Folin M et al. 2009; Structural characterisation and cell response evaluation of electrospun PCL membranes: micrometric vs sub-micrometric fibers. J Biomed Mater Res A 89: 1028-1039.
19. Del Gaudio C, Ercolani E, Nanni F et al. 2011; Assessment of poly(ε-caprolactone)/poly(3-hydroxybutyrate-co-3-hydroxyvalerate) blends processed by solvent casting and electrospinning. Mater Sci Eng A 528: 1764-1772.
20. Del Gaudio C, Fioravanzo L, Folin M et al. 2012; Electrospun tubular scaffolds: on the effectiveness of blending poly(ε-caprolactone) with poly(3-hydroxybutyrate-co-3-hydroxyvalerate). J Biomed Mater Res B 100B: 1883-1898.
21. Dentelli P, Rosso A, Balsamo A et al. 2007; C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 109: 4264-4271.
22. Dimitrievska S, Maire M, Diaz-Quijada GA et al. 2011; Low thrombogenicity coating of nonwoven PET fiber structures for vascular grafts. Macromol Biosci 11: 493-502.
23. Dinarvand R, Sepehri N, Manoochehri S et al. 2011; Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomed 6: 877-895.
24. Dong Y, Yong T, Liao S et al. 2008; Long-term viability of coronary artery smooth muscle cells on poly(l-lactide-co-ε-caprolactone) nanofibrous scaffold indicates its potential for blood vessel tissue engineering. J R Soc Interface 5: 1109-1118.
25. Dong Y, Yong T, Liao S et al. 2010; Distinctive degradation behaviors of electrospun polyglycolide, poly(dl-lactide-co-glycolide) and poly(l-lactide-co-ε-caprolactone) nanofibers cultured with/without porcine smooth muscle cells. Tissue Eng Part A 16: 283-298.
26. Donovan DL, Schrnidt SP, Townshend SP et al. 1990; Material and structural characterization of human saphenous vein. J Vasc Surg 12: 531-537.
27. Drilling S, Gaumer J, Lannutti J. 2009; Fabrication of burst pressure competent vascular grafts via electrospinning: effects of microstructure. J Biomed Mater Res A 88: 923-934.
28. Du F, Wang H, Zhao W et al. 2012; Gradient nanofibrous chitosan/poly(ε-caprolactone) scaffolds as extracellular microenvironments for vascular tissue engineering. Biomaterials 33: 762-770.
29. Edlund U, Albertsson AC. 2002; Degradable polymer microspheres for controlled drug delivery. Adv Polym Sci 157: 67-112.
30. Francis SH, Busch JL, Corbin JD. 2010; cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62: 525-563.
31. Furukawa KS, Ushida T, Toita K et al. 2002; Hybrid of gel-cultured smooth muscle cells with PLLA sponge as a scaffold towards blood vessel regeneration. Cell Transpl 11: 475-480.
32. Garg K, Sell SA, Madurantakam P et al. 2009; Angiogenic potential of human macrophages on electrospun bioresorbable vascular grafts. Biomed Mater 4: 031001.
33. Gauvin R, Ahsan T, Larouche D et al. 2010; A novel single-step self-assembly approach for the fabrication of tissue-engineered vascular constructs. Tissue Eng Part A 16: 1737-1747.
34. Gaziano TA. 2005; Cardiovascular disease in the developing world and its cost-effective management. Circulation 112: 3547-3553.
35. Grasl C, Bergmeister H, Stoiber M et al. 2010; Electrospun polyurethane vascular grafts: in vitro mechanical behavior and endothelial adhesion molecule expression. J Biomed Mater Res A 93: 716-723.
36. Greisler HP, Ellinger J, Schwarcz TH et al. 1987; Arterial regeneration over polydioxanone prostheses in the rabbit. Arch Surg 122: 715-721.
37. Hajiali H, Shahgasempour S, Naimi-Jamal MR et al. 2011; Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering. Int J Nanomed 6: 2133-2141.
38. He W, Ma Z, Yong T et al. 2005; Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 26: 7606-7615.
39. Heilshorn SC, Liu JC, Tirrell DA. 2005; Cell-binding domain context affects cell behavior on engineered proteins. Biomacromolecules 6: 318-323.
40. Heydarkhan-Hagvall S, Schenke-Layland K, Dhanasopon AP et al. 2008; Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials 29: 2907-2914.
41. Horan RL, Antle K, Collette AL et al. 2005; In vitro degradation of silk fibroin. Biomaterials 26: 3385-3393.
42. Hristov M, Zernecke A, Bidzhekov K et al. 2007; Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 100: 590-597.
43. Huang C, Chen R, Ke Q et al. 2011; Electrospun collagen-chitosan-TPU nanofibrous scaffolds for tissue engineered tubular grafts. Colloids Surf B Biointerfaces 82: 307-315.
44. Huang L, Nagapudi K, Apkarian RP et al. 2001; Engineered collagen-PEO nanofibers and fabrics. J Biomater Sci Polym Edn 12: 979-993.
45. Huang ZM, Zhang YZ, Kotakic M et al. 2003; A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol 63: 2223-2253.
46. Innocente F, Mandracchia D, Pektok E et al. 2009; Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? Circulation 120(suppl 11): S37-45.
47. Inoguchi H, Kwon IK, Inoue E et al. 2006; Mechanical responses of a compliant electrospun poly(l-lactide-co-ε-caprolactone) small-diameter vascular graft. Biomaterials 27: 1470-1478.
48. Isenberg BC, Williams C, Tranquillo RT. 2006; Small-diameter artificial arteries engineered in vitro. Circ Res 98: 25-35.
49. Jacob MP, Badier-Commander C, Fontaine V et al. 2001; Extracellular matrix remodeling in the vascular wall. Pathol Biol 49: 326-332.
50. Jeong SI, Kim SY, Cho SK et al. 2007; Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors. Biomaterials 28: 1115-1122.
51. Kapadia MR, Popowich DA, Kibbe MR. 2008; Modified prosthetic vascular conduits. Circulation 117: 1873-1882.
52. Katti DS, Lakshmi S, Langer R et al. 2002; Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev 54: 933-961.
53. Kelleher CM, McLean SE, Mecham RP. 2004; Vascular extracellular matrix and aortic development. Curr Top Dev Biol 62: 153-188.
54. Khandwekar AP, Patil DP, Shouche Y et al. 2011; Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility. J Biomater Appl 26: 227-252.
55. Kim MJ, Kim JH, Yi G et al. 2008; In vitro and in vivo application of PLGA nanofiber for artificial blood vessels. Macromol Res 16: 345-352.
56. Konig G, McAllister TN, Dusserre N et al. 2009; Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 30: 1542-1550.
57. Kwon IK, Matsuda T. 2005; Co-electrospun nanofiber fabrics of poly(l-lactide-co-ε-caprolactone) with type I collagen or heparin. Biomacromolecules 6: 2096-2105.
58. L'Heureux N, Dusserre N, Konig G et al. 2006; Human tissue engineered blood vessel for adult arterial revascularization. Nat Med 12: 361-365.
59. Lannutti J, Reneker D, Ma T et al. 2007; Electrospinning for tissue engineering scaffolds. Mater Sci Eng C 27: 504-509.
60. Labarre D. 2001; Improving blood-compatibility of polymeric surface. Trends Biomater Artif Organs 15: 1-3.
61. Lee SJ, Liu J, Oh SH et al. 2008; Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 29: 2891-2898.
62. Lee SJ, Yoo JJ, Lim GJ et al. 2007; In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res A 83: 999-1008.
63. Li M, Mondrinos MJ, Chen X et al. 2006; Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds. J Biomed Mater Res A 79: 963-973.
64. Li M, Mondrinos MJ, Gandhi MR et al. 2005; Electrospun protein fibers as matrices for tissue engineering. Biomaterials 26: 5999-6008.
65. Liu H, Li X, Zhou G et al. 2011; Electrospun sulfated silk fibroin nanofibrous scaffolds for vascular tissue engineering. Biomaterials 32: 3784-3793.
66. Luong-Van E, Grøndahl L, Chua KN et al. 2006; Controlled release of heparin from poly(ε-caprolactone) electrospun fibers. Biomaterials 27: 2042-2050.
67. Ma Z, Kotaki M, Yong T, He W et al. 2005; Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials 26: 2527-2536.
68. Marelli B, Alessandrino A, Farè S et al. 2010; Compliant electrospun silk fibroin tubes for small vessel bypass grafting. Acta Biomater 6: 4019-4026.
69. Mattanavee W, Suwantong O, Puthong S et al. 2009; Immobilization of biomolecules on the surface of electrospun polycaprolactone fibrous scaffolds for tissue engineering. ACS Appl Mater Interfaces 1: 1076-1085.
70. Matthews JA, Wnek GE, Simpson DG et al. 2002; Electrospinning of collagen nanofibers. Biomacromolecules 3: 232-238.
71. Maurus PB, Kaeding CC. 2004; Bioabsorbable implant material review. Oper Tech Sports Med 12: 158-160.
72. McClure MJ, Sell SA, Ayres CE et al. 2009; Electrospinning-aligned and random polydioxanone-polycaprolactone-silk fibroin-blended scaffolds: geometry for a vascular matrix. Biomed Mater 4: 055010.
73. McClure MJ, Sell SA, Simpson DG et al. 2010; A three-layered electrospun matrix to mimic native arterial architecture using polycaprolactone, elastin, and collagen: a preliminary study. Acta Biomater 6: 2422-2433.
74. McKenna KA, Hinds MT, Sarao RC et al. 2012; Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials. Acta Biomater 8: 225-233.
75. Mohan R, Amsel BJ, Walter PJ. 1992; Coronary artery bypass grafting in the elderly - a review of studies on patients older than 64, 69 or 74 years. Cardiology 80: 215-225.
76. Nair LS, Laurencin CT. 2007; Biodegradable polymers as biomaterials. Prog Polym Sci 32: 762-798.
77. Nottelet B, Pektok E, Mandracchia D et al. 2009; Factorial design optimization and in vivo feasibility of poly(ε-caprolactone)-micro- and nanofiber-based small diameter vascular grafts. J Biomed Mater Res A 89: 865-875.
78. Olsen D, Yang C, Bodo M et al. 2003; Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev 55: 1547-1567.
79. Ortel TL. 2009; Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. Hematol Am Soc Hematol Educ Program. DOI:10.1182/asheducation-2009.1.225
80. Panzavolta S, Gioffrè M, Focarete ML et al. 2011; Electrospun gelatin nanofibers: optimization of genipin cross-linking to preserve fiber morphology after exposure to water. Acta Biomater 7: 1702-1709.
81. Park IS, Kim SH, Kim YH et al. 2009; A collagen/smooth muscle cell-incorporated elastic scaffold for tissue-engineered vascular grafts. J Biomater Sci Polym Ed 20: 1645-1660.
82. Pektok E, Nottelet B, Tille JC et al. 2008; Degradation and healing characteristics of small-diameter poly(ε-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 118: 2563-2570.
83. Puppi D, Detta N, Piras AM et al. 2010; Development of electrospun three-arm star poly(ε-caprolactone) meshes for tissue engineering applications. Macromol Biosci 10: 887-897.
84. Qiu Y, Zhang N, Kang Q et al. 2009; Fabrication of permeable tubular constructs from chemically modified chitosan with enhanced antithrombogenic property. J Biomed Mater Res B 90B: 668-678.
85. Rabkin E, Schoen FJ. 2002; Cardiovascular tissue engineering. Cardiovasc Pathol 11: 305-317.
86. Ravi S, Qu Z, Chaikof EL. 2009; Polymeric materials for tissue engineering of arterial substitutes. Vascular 17: S45-54.
87. Rodenberg EJ, Pavalko FM. 2007; Peptides derived from fibronectin type III connecting segments promote endothelial cell adhesion but not platelet adhesion: implications in tissue-engineered vascular grafts. Tissue Eng 13: 2653-2666.
88. Sallach RE, Cui W, Wen J et al. 2009; Elastin-mimetic protein polymers capable of physical and chemical crosslinking. Biomaterials 30: 409-422.
89. Santin M, Motta A, Freddi G et al. 1999; In vitro evaluation of the inflammatory potential of the silk fibroin. J Biomed Mater Res 46: 382-389.
90. Sarkar S, Burriesci G, Wojcik A et al. 2009; Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion phase-inversion method and nanocomposite polymer. J Biomech 42: 722-730.
91. Sarkar S, Schmitz-Rixen T, Hamilton G et al. 2007; Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Med Biol Eng Comput 45: 327-336.
92. Sell SA, McClure MJ, Barnes CP et al. 2006; Electrospun polydioxanone-elastin blends: potential for bioresorbable vascular grafts. Biomed Mater 1: 72-80.
93. Sell SA, McClure MJ, Garg K et al. 2009; Electrospinning of collagen/biopolymers for regenerative medicine and cardiovascular tissue engineering. Adv Drug Deliv Rev 61: 1007-1019.
94. Serrano MC, Pagani R, Peña J et al. 2011; Progenitor-derived endothelial cell response, platelet reactivity and haemocompatibility parameters indicate the potential of NaOH-treated polycaprolactone for vascular tissue engineering. J Tissue Eng Regen Med 5: 238-247.
95. Smith MJ, McClure MJ, Sell SA et al. 2008; Suture-reinforced electrospun polydioxanone-elastin small-diameter tubes for use in vascular tissue engineering: a feasibility study. Acta Biomater 4: 58-66.
96. Soffer L, Wang X, Zhang X et al. 2008; Silk-based electrospun tubular scaffolds for tissue-engineered vascular grafts. J Biomater Sci Polym Ed 19: 653-664.
97. Stankus JJ, Guan J, Fujimoto K et al. 2006; Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 27: 735-744.
98. Telemeco TA, Ayres C, Bowlin GL et al. 2005; Regulation of cellular infiltration into tissue engineering scaffolds composed of submicron diameter fibrils produced by electrospinning. Acta Biomater 1: 377-385.
99. Thomas V, Donahoe T, Nyairo E et al. 2011; Electrospinning of Biosyn®-based tubular conduits: structural, morphological, and mechanical characterizations. Acta Biomater 7: 2070-2079.
100. Thomas V, Zhang X, Catledge SA et al. 2007; Functionally graded electrospun scaffolds with tunable mechanical properties for vascular tissue regeneration. Biomed Mater 2: 224-32.
101. Thomas V, Zhang X, Vohra YK. 2009; A biomimetic tubular scaffold with spatially designed nanofibers of protein/PDS bio-blends. Biotechnol Bioeng 104: 1025-1033.
102. Tillman BW, Yazdani SK, Lee SJ et al. 2009; The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials 30: 583-588.
103. Timmins LH, Wu Q, Yeh AT et al. 2010; Structural inhomogeneity and fiber orientation in the inner arterial media. Am J Physiol Heart Circ Physiol 298: H1537-1545.
104. Uttayarat P, Perets A, Li M et al. 2010; Micropatterning of three-dimensional electrospun polyurethane vascular grafts. Acta Biomater 6: 4229-4237.
105. Vaz CM, van Tuijl S, Bouten CV et al. 2005; Design of scaffolds for blood vessel tissue engineering using a multi-layering electrospinning technique. Acta Biomater 1: 575-582.
106. Vert M. 2011; Degradable polymers in medicine: updating strategies and terminology. Int J Artif Organs 34: 76-83.
107. Vroman L, Adams AL, Fischer GC et al. 1980; Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55:156-159.
108. Wang C, Cen L, Yin S et al. 2010; A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 31: 621-630.
109. Wang S, Zhang Y, Wang H et al. 2011; Preparation, characterization and biocompatibility of electrospinning heparin-modified silk fibroin nanofibers. Int J Biol Macromol 48: 345-353.
110. Wang S, Zhang Y, Wang H et al. 2009; Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold. Biomacromolecules 10: 2240-2244.
111. Weinberg SL, Cipolletti GB, Turner RJ. 1982; Human Umbilical Vein Grafts: Physical Evaluation Criteria for Biological and Synthetic Vascular Prostheses, Stanley JC (ed.). Grune and Stratton: New York.
112. Williams DF. 1987; Definitions in Biomaterials. Progress in Biomedical Engineering. Elsevier: Amsterdam; 72.
113. Wise SG, Byrom MJ, Waterhouse A et al. 2011; A multilayered synthetic human elastinpolycaprolactone hybrid vascular graft with tailored mechanical properties. Acta Biomater 7: 295-303.
114. Wong SC, Baji A, Leng S. 2008; Effect of fiber diameter on tensile properties of electrospun poly(ε-caprolactone). Polymer 49: 4713-4722.
115. Woodruff MA, Hutmacher DW. 2010; The return of a forgotten polymer-Polycaprolactone in the 21st century. Progr Polymer Sci 35: 1217-1256.
116. Wu H, Fan J, Chu CC et al. 2010; Electrospinning of small diameter 3D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci Mater Med 21: 3207-3215.
117. Wulf K, Teske M, Löbler M et al. 2011; Surface functionalization of poly(ε-caprolactone) improves its biocompatibility as scaffold material for bioartificial vessel prostheses. J Biomed Mater Res B Appl Biomater 98: 89-100.
118. Xiao Y, Truskey GA. 1996; Effect of receptor-ligand affinity on the strength of endothelial cell adhesion. Biophys J 71: 2869-2884.
119. Xu CY, Inai R, Kotaki M et al. 2004; Aligned biodegradable nanofibrous structure, a potential scaffold for blood vessel engineering. Biomaterials 25: 877-886.
120. Yoo HS, Kim TG, Park TG. 2009; Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev 61: 1033-1042.
121. Yusuf S, Ounpuu S, Anand S. 2002; The global epidemic of atherosclerotic cardiovascular disease. Med Princip Pract 11: 3-8.
122. Zeng J, Chen XS, Liang QZ et al. 2004; Enzymatic degradation of poly(l-lactide) and poly(ε-caprolactone) electrospun fibers. Macromol Biosci 4: 1118-1125.
123. Zhang X, Thomas V, Xu Y et al. 2010a; An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold. Biomaterials 31: 4376-4381.
124. Zhang X, Thomas V, Vohra YK. 2010b; Two-ply tubular scaffolds comprised of proteins/poliglecaprone/polycaprolactone fibers. J Mater Sci Mater Med 21: 541-549.
125. Zhang K, Wang H, Huang C et al. 2010c; Fabrication of silk fibroin blended P(LLA-CL) nanofibrous scaffolds for tissue engineering. Biomed Mater Res A 93: 984-993.
126. Zhu Y, Cao Y, Pan J, Liu Y. 2010; Macro-alignment of electrospun fibers for vascular tissue engineering. J Biomed Mater Res B Appl Biomater 92: 508-516.
127. Zhu Y, Gao C, Liu X, Shen J. 2002; Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules 3: 1312-1319.
128. Zilberman M, Nelson KD, Eberhart RC. 2005; Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents. Biomed Mater Res B Appl Biomater 74: 792-799.
129. Zilla P, Bezuidenhout D, Human P. 2007; Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 28: 5009-5027.